Global Veterinary Vaccine Supply, Demand and Key Producers, 2026-2032

The global Veterinary Vaccine market size is expected to reach $ 21330 million by 2032, rising at a market growth of 6.8% CAGR during the forecast period (2026-2032).

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.

Factors influencing growth in demand for farm vaccines include:

• human population growth and increasing standards of living, particularly in many emerging markets;

• increasing demand for improved nutrition, particularly animal protein;

• natural resource constraints, such as scarcity of arable land, fresh water and increased competition for cultivated land, resulting in fewer resources that will be available to meet this increased demand for animal protein;

• increasing urbanization and increased focus on food safety and food security. Rising concerns over food security and increasing animal husbandry are boosting the demand for animal vaccines for the livestock population. Increasing demand for animal products has led to growth in livestock production globally.

The primary companion animal species are dogs, cats and horses. Factors influencing growth in demand for companion animal vaccines include:

• economic development and related increases in disposable income, particularly in many emerging markets;

• increasing pet ownership

• companion animals living longer, increasing medical treatment of companion animals and advances in companion animal medicines and vaccines.

North Americas is the largest consumption place, with a consumption market share nearly 36% in 2023. Following North Americas, APAC is the second largest consumption place with the consumption market share of 30%.

Global key Veterinary Vaccine players cover Merck, Boehringer Ingelheim, Zoetis, Elanco, Ceva, CAHIC, Jinyu Bio-Technology, HVRI, Ringpu Biology, Virbac, etc. In terms of revenue, the global five largest companies occupied for a share nearly 75.64% in 2023.

This report studies the global Veterinary Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Veterinary Vaccine and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Veterinary Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Veterinary Vaccine total production and demand, 2021-2032, (M Doses)

Global Veterinary Vaccine total production value, 2021-2032, (USD Million)

Global Veterinary Vaccine production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (M Doses), (based on production site)

Global Veterinary Vaccine consumption by region & country, CAGR, 2021-2032 & (M Doses)

U.S. VS China: Veterinary Vaccine domestic production, consumption, key domestic manufacturers and share

Global Veterinary Vaccine production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (M Doses)

Global Veterinary Vaccine production by Type, production, value, CAGR, 2021-2032, (USD Million) & (M Doses)

Global Veterinary Vaccine production by Application, production, value, CAGR, 2021-2032, (USD Million) & (M Doses)

This report profiles key players in the global Veterinary Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio, DHN, WINSUN, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Veterinary Vaccine market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Doses) and average price (USD/K Doses) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global Veterinary Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Veterinary Vaccine Market, Segmentation by Type:
Live Attenuated Vaccines
Inactivated Vaccines
Other

Global Veterinary Vaccine Market, Segmentation by Application:
Farm Animal
Companion Animal

Companies Profiled:
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco
Virbac
Jinyu Bio-Technology
Medion
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Bio-Labs
Avimex Animal Health
MEVAC
Biovac
Atafen
Dyntec
RVSRI

Key Questions Answered:

1. How big is the global Veterinary Vaccine market?

2. What is the demand of the global Veterinary Vaccine market?

3. What is the year over year growth of the global Veterinary Vaccine market?

4. What is the production and production value of the global Veterinary Vaccine market?

5. Who are the key producers in the global Veterinary Vaccine market?

6. What are the growth factors driving the market demand? Show more